Clinical trial
Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C…
NCT00248339 · Virginia Commonwealth University, Other · Completed
Key facts
| NCT number | NCT00248339 |
|---|---|
| Title | Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection |
| Official title | An Open-label, Randomized Pilot Study to Compare the Effectiveness of Peginterferon-alfa-2b Plus Ribavirin to Peginterferon-alfa-2b Plus Epoetin-alfa and Two Doses of Ribavirin in the Treatment of Chronic Hepatitis C Virus Infection |
| Lead sponsor | Virginia Commonwealth University, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Peginterferon-alpha-2b (PEG-Intron), Ribavirin, Epoetin-alpha (Procrit) |
| Enrollment | 150 |
| Start date | May 1, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Nov 3, 2005 |
| Last update posted | Mar 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: